M

Mega Lifesciences PCL
SET:MEGA

Watchlist Manager
Mega Lifesciences PCL
SET:MEGA
Watchlist
Price: 33.75 THB -1.46% Market Closed
Market Cap: 29.4B THB

Relative Value

The Relative Value of one MEGA stock under the Base Case scenario is hidden THB. Compared to the current market price of 33.75 THB, Mega Lifesciences PCL is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

MEGA Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
73
vs Industry
54
Median 3Y
2.2
Median 5Y
2.3
Industry
2.6
Forward
2
vs History
79
vs Industry
32
Median 3Y
16.7
Median 5Y
17.9
Industry
21.6
Forward
15.2
vs History
85
vs Industry
33
Median 3Y
15.9
Median 5Y
16.1
Industry
16.5
vs History
87
vs Industry
28
Median 3Y
19
Median 5Y
21.4
Industry
22.5
vs History
79
vs Industry
26
Median 3Y
3.6
Median 5Y
4
Industry
2.3
vs History
76
vs Industry
57
Median 3Y
2
Median 5Y
2.2
Industry
2.9
Forward
1.8
vs History
79
vs Industry
58
Median 3Y
4.2
Median 5Y
4.8
Industry
5.5
vs History
77
vs Industry
41
Median 3Y
9.7
Median 5Y
11.7
Industry
13
Forward
8.5
vs History
77
vs Industry
42
Median 3Y
10.6
Median 5Y
12.8
Industry
16.6
Forward
9.6
vs History
85
vs Industry
38
Median 3Y
14.3
Median 5Y
15.1
Industry
15.8
vs History
79
vs Industry
30
Median 3Y
17.1
Median 5Y
17.8
Industry
19.1
vs History
79
vs Industry
26
Median 3Y
3.4
Median 5Y
3.6
Industry
1.9

Multiples Across Competitors

MEGA Competitors Multiples
Mega Lifesciences PCL Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
TH
Mega Lifesciences PCL
SET:MEGA
29.4B THB 2.1 14.9 7.9 8.6
US
Eli Lilly and Co
NYSE:LLY
971.9B USD 16.4 52.8 35.5 38
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
509.1B USD 5.5 20.3 16.6 21.5
CH
Roche Holding AG
SIX:ROG
252.3B CHF 4.1 26.8 11.5 13.4
UK
AstraZeneca PLC
LSE:AZN
208.5B GBP 4.8 29.7 108.2 158.3
CH
Novartis AG
SIX:NOVN
202.4B CHF 4.5 17.7 11.2 14.5
US
Merck & Co Inc
NYSE:MRK
249.5B USD 3.9 13.1 9.3 11.1
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK 4.5 13.7 9.6 11.2
IE
Endo International PLC
LSE:0Y5F
209B USD 90.1 -71.5 331.1 830.4
US
Pfizer Inc
NYSE:PFE
147B USD 2.3 15 7.6 10.4
P/E Multiple
Earnings Growth PEG
TH
M
Mega Lifesciences PCL
SET:MEGA
Average P/E: 22.7
14.9
6%
2.5
US
Eli Lilly and Co
NYSE:LLY
52.8
53%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
20.3
29%
0.7
CH
Roche Holding AG
SIX:ROG
26.8
29%
0.9
UK
AstraZeneca PLC
LSE:AZN
29.7
38%
0.8
CH
Novartis AG
SIX:NOVN
17.7
17%
1
US
Merck & Co Inc
NYSE:MRK
13.1
15%
0.9
DK
Novo Nordisk A/S
CSE:NOVO B
13.7
4%
3.4
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -71.5 N/A N/A
US
Pfizer Inc
NYSE:PFE
15
29%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
TH
M
Mega Lifesciences PCL
SET:MEGA
Average EV/EBITDA: 399.5
7.9
-1%
N/A
US
Eli Lilly and Co
NYSE:LLY
35.5
33%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16.6
9%
1.8
CH
Roche Holding AG
SIX:ROG
11.5
4%
2.9
UK
AstraZeneca PLC
LSE:AZN
108.2
10%
10.8
CH
Novartis AG
SIX:NOVN
11.2
6%
1.9
US
Merck & Co Inc
NYSE:MRK
9.3
6%
1.6
DK
Novo Nordisk A/S
CSE:NOVO B
9.6
2%
4.8
IE
E
Endo International PLC
LSE:0Y5F
331.1
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.6
1%
7.6
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
TH
M
Mega Lifesciences PCL
SET:MEGA
Average EV/EBIT: 1 710.9
8.6
-1%
N/A
US
Eli Lilly and Co
NYSE:LLY
38
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
21.5
15%
1.4
CH
Roche Holding AG
SIX:ROG
13.4
5%
2.7
UK
AstraZeneca PLC
LSE:AZN
158.3
23%
6.9
CH
Novartis AG
SIX:NOVN
14.5
12%
1.2
US
Merck & Co Inc
NYSE:MRK
11.1
8%
1.4
DK
Novo Nordisk A/S
CSE:NOVO B
11.2
1%
11.2
IE
E
Endo International PLC
LSE:0Y5F
830.4
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.4
8%
1.3